Tag: AMyris

Amyris gets green light for zero-calorie sweetener made from sugarcane

Amyris gets green light for zero-calorie sweetener made from sugarcane

September 3, 2018 |

In California, Amyris, Inc. announced that its zero-calorie sweetener made from sugarcane has received designation as GRAS (Generally Recognized as Safe) by an independent expert panel. This designation is based on FDA requirements and allows Amyris to begin commercially selling its new, natural, zero-calorie sweetener. Amyris plans to commercially launch its sweetener during the fourth […]

Read More

Top 10 Transformations – Pivotal Pivots for survival in the bioeconomy

Top 10 Transformations – Pivotal Pivots for survival in the bioeconomy

July 15, 2018 |

We frequently hear that the only constant is change and in today’s bioeconomy world, we see this lived out all the time. Companies come and go but some evolve, transform, and change. Today we focus on some of these pivotal pivots and the transformations with these leaders who live and breathe change to survive. Some […]

Read More

Amyris closes on $36 million term loan and additional accordion facility

Amyris closes on $36 million term loan and additional accordion facility

July 2, 2018 |

In California, Amyris, Inc. has closed on a $36 million term loan with Great American Capital Partners, LLC, a subsidiary of B. Riley Capital Management, LLC, an SEC Registered Investment Advisor and wholly-owned subsidiary of B. Riley Financial, Inc. Cash from the term loan will be used to pay off the company’s Stegodon and other short-term debt […]

Read More

Amyris teams with Portuguese universities to boost AI and use of wastes

Amyris teams with Portuguese universities to boost AI and use of wastes

June 13, 2018 |

In California, Amyris announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the […]

Read More

Amyris wins two grants for about $25 million

Amyris wins two grants for about $25 million

January 18, 2018 |

In California, Amyris announced two grants that have been awarded, valued in aggregate at approximately $25 million, to accelerate innovation and enable the company to further extend its leadership position in the industrial biotechnology sector. The first grant is in Europe and focused on furthering the company’s current artificial intelligence (AI) and Informatics platform at […]

Read More

H&R makes equity investment into Novvi joint venture

H&R makes equity investment into Novvi joint venture

October 28, 2017 |

In Germany, H&R USA, a company of The Hansen & Rosenthal Group, of Hamburg (Germany), and Novvi LLC (California) today announced that H&R has made an equity investment into Novvi LLC, a joint venture of Amyris, Inc., Cosan S.A., American Refining Group and Chevron USA. Terms of the transaction were not disclosed. Novvi’s products and […]

Read More

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

October 26, 2017 |

  We reported on Amyris’ progress recently in “The New Colossus aims to unlock its Golden Door” and in Two Up: Amyris, Queensland gamble on farnesene for SE Asia. Meanwhile, Amyris President of R&D Joel Cherry presented these illuminating slides on the company’s progress at ABLC 2017 in San Francisco.

Read More

Amyris announces second product development tie up with Royal DSM

Amyris announces second product development tie up with Royal DSM

September 26, 2017 |

In California, Amyris, Inc. announced that it has entered into a product development and production agreement for Vitamin A with Koninklijke DSM N.V. This marks the second such agreement between the two parties. DSM is partnering with Amyris to fund the development of the technology to produce Vitamin A on a cost-advantaged basis utilizing Amyris’s […]

Read More

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

September 21, 2017 |

In California, Amyris reported Q2 2017 revenues of $25.7M million, more than double the sales from 2016. The increase was driven by a major increase in product sales, primarily in the company’s personal care segment, as well as by significantly higher collaboration revenues. For many people, the key question is — what is Amyris becoming, and […]

Read More

Earnings season: An advanced bioecononomy’s health and wellness check-up

Earnings season: An advanced bioecononomy’s health and wellness check-up

August 14, 2017 |

In today’s Digest, let’s look at trends driving the industry’s results at scale — and while money is not the measure of all progress, it is the ultimate yardstick and especially for companies that have reached industrial scale. So, let’s look at Q2 earnings statements now just coming out from four of the sector’s signature […]

Read More